Türk Medline
ADR Yönetimi
ADR Yönetimi

CAN A DEDICATED MULTIDISCIPLINARY TUMOR BOARD IMPROVE PERSONALIZED MEDICINE FOR PATIENTS IN INTERVENTIONAL ONCOLOGY? A LARGE RETROSPECTIVE SINGLE-CENTER EXPERIENCE

ROBERTO IEZZI, BRUNO FIONDA, PATRİZİA CORNACCHİONE, MARTİNA IEZZI, VALENTİNA LANCELLOTTA, ANDREA CONTEGIACOMO, FABİA ATTILI, ALBERTO LARGHI, FRANCESCO CELLINI, FABİO MARAZZI, GİUSEPPE COLLOCA, ÁNGELES ROVIROSA, GYÖRGY KOVÁCS, MARİA ANTONİETTA GAMBACORTA, RİCCARDO MANFREDI, VİNCENZO VALENTINI, LUCA TAGLIAFERRI

Turkish Journal of Oncology - 2022;37(2):192-199

Department of Diagnostic Imaging, Fondazione Policlinico Universitario ?A. Gemelli? IRCCS, Radiation Oncology and Hematology, U.O.C. of Diagnostic and General Interventional Radiology, Rome-Italy

 

OBJECTIVE< br> Interventional oncology (IO) offers minimal invasive oncological procedures to personalize therapeutic approaches. We aimed at assessing potential advantages of an IO multidisciplinary tumor board (INTER-BOARD) in terms of waiting time, procedural adverse events, and length of hospital stay. METHODS We retrospectively evaluated all patients managed at our institutional INTER-BOARD from January 2018 to June 2019. Outcome measurements such as number of patients managed in each semester, median interval time between initial assessment and admission to the hospital, total number of procedures, procedures type, adverse events, and complication-related days of hospital stay were analyzed. RESULTS The INTER-BOARD discussed 438 patients (mean age 64 years; range 27-92) during the study period. Overall, 203 procedures were performed in patients >65 years and 49 in patients >80 years. The number of patients discussed progressively increased over time 82 (18.7%) during the first semester, 120 (27.4%) during the second semester, and 236 (54.1%) in the third semester. Patients with 33 different cancer types were discussed and 22 different procedure types were performed. Mean hospitalization time was 4 days (progressively decreasing over time from 5 to 3 days). Adverse events occurred in 4% of cases, with a progressively decreasing rate over time (16%, 5%, and 3% for 1st, 2nd, and 3rd semester, respectively). CONCLUSION In our experience, the dedicated INTER-BOARD allowed optimization of patient care through critical evaluation of all treatment options offered by different specialists. This approach reached optimal treatment results, with low adverse events, and reduced waiting, as well as hospitalization time.